Nucl Med Mol Imaging.  2009 Aug;43(4):259-279.

Are Medical Personnel Safe from Radiation Exposure from Patient Receiving Radioiodine Ablation Therapy?

Affiliations
  • 1Department of Nuclear Medicine, Wonkwang University School of Medicine, Iksan, Jeonbuk, Korea. leokim@wonkwang.ac.kr

Abstract

Radioiodine ablation therapy has been considered to be a standard treatment for patient with differentiated thyroid cancer after total thyroidectomy. Patients may need to be hospitalized to reduce radiation exposure of other people and relatives from radioactive patients receiving radioiodine therapy. Medical staffs, nursing staffs and technologists sometimes hesitate to contact patients in radioiodine therapy ward. The purpose of this paper is to introduce radiation dosimetry, estimate radiation dose from patients and emphasize the safety of radiation exposure from patients treated with high dose radioiodine in therapy ward. The major component of radiation dose from patient is external exposure. However external radiation dose from these patients treated with typical therapeutic dose of 4 to 8 GBq have a very low risk of cancer induction compared with other various risks occurring in daily life. The typical annual radiation dose without shielding received by patient is estimated to be 5 to 10 mSv, which is comparable with 100 to 200 times effective dose received by chest PA examination. Therefore, when we should keep in mind the general principle of radiation protection, the risks of radiation exposure from patients are low and the medical personnel are considered to be safe from radiation exposure.

Keyword

Radioiodine ablation therapy; thyroid neoplasm; radiation protection; radiation dosimetry; internal dosimetry

MeSH Terms

Humans
Medical Staff
Nursing Staff
Radiation Protection
Radiometry
Thorax
Thyroid Neoplasms
Thyroidectomy
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr